RecruitingNCT06497868

Self-compassion and Bipolar Disorder

Self-compassion and Bipolar Disorder: Evaluation of the Feasibility and Preliminary Effectiveness of Two Psychological Therapies Targeting Self-compassion


Sponsor

University Hospital, Strasbourg, France

Enrollment

10 participants

Start Date

Jun 20, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Currently, pharmacotherapy is central in the management of bipolar disorder (BD), but does not guarantee satisfactory results for many patients. Existing psychotherapies, notably cognitive-behavioral therapy (CBT), show some effectiveness, but do not target the mechanisms that maintain the disorder. Indeed, people with BD present a low level of self-compassion, suffer from comorbidities (e.g. anxiety, depression), and have a high level of emotional dysregulation, which can contribute to increasing the risk of relapse and mood instability. In this context, it has been suggested that interventions targeting self-compassion could reduce BD psychopathology and strengthen emotional regulation skills. Two psychological therapies targeting self-compassion could be promising in the treatment of BD: Compassion-Based Therapy (CBT) and Cognitive Therapy focused on Mental Imagery (mTCI). These approaches partly emphasize compassionate mental imagery to promote self-soothing and emotion management skills. Studies on the feasibility and effectiveness of CBT and mTCI in the context of BD are few in number, and do not focus on their impact on emotional regulation abilities. Evaluating these therapies could lead to the development of more specific and effective interventions for people with TB.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring the relationship between self-compassion and how people with bipolar disorder cope with and experience their condition, using data already collected from patient medical records. **You may be eligible if...** - You are 18 or older - You have been diagnosed with bipolar disorder and were seen as an outpatient, day hospital patient, or in another setting between January 2022 and February 2024 - You have not previously objected to your data being used for scientific research **You may NOT be eligible if...** - You have objected to your medical data being used for research purposes - You were subject to court-ordered or involuntary psychiatric treatment - You are legally deprived of liberty Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service de Psychiatrie - CHU de Strasbourg - France

Strasbourg, Les Hôpitaux Universitaires de Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06497868


Related Trials